Volume 29, Number 5—May 2023
Dispatch
Fatal Case of Heartland Virus Disease Acquired in the Mid-Atlantic Region, United States
Table
Test | Reference range | Days after symptom onset |
||||
---|---|---|---|---|---|---|
5 | 7 | 9 | 11 | 13 | ||
Temperature, °C |
35.5–38.3 |
36.8 |
38.5 |
38.5 |
39.1 |
36.9 |
Blood cell counts | ||||||
Leukocyte count, × 103 cells/μL | 4.50–11.00 | 2.4 | 3.7 | 3.5 | 2.48 | 3.25 |
Absolute neutrophil count, cells/μL | 1.50–7.80 | ND | ND | ND | 0.99 | 0.88 |
Absolute lymphocyte count, cells/μL | 1.10–4.80 | ND | ND | ND | 1.22 | 1.76 |
Hemoglobin, g/dL | 13.9–16.3 | 14.5 | 14.9 | 14.6 | 14.4 | 11.7 |
Platelets, × 103/μL |
150–350 |
178 |
106 |
82 |
59 |
61 |
Blood chemistry test results | ||||||
Sodium, mmol/L | 135–148 | 126 | 115 | 120 | 129 | 136 |
Potassium, mmol/L | 3.5–5.1 | 3.7 | 3.3 | 4.2 | 4.4 | 4.4 |
Carbon dioxide, mmol/L | 21–31 | 22 | 22 | 20 | 17 | 18 |
Anion gap, mmol/L | 7–16 | 13 | 15 | 12 | 12 | 11 |
Blood urea nitrogen, mg/dL | 7–22 | 12 | 12 | 16 | 26 | 68 |
Creatinine, mg/dL | 0.6–1.3 | 1.0 | 1.3 | 1.2 | 1.4 | 4.4 |
Aspartate aminotransferase, units/L | <37 | 45 | 359 | 434 | 590 | 617 |
Alanine aminotransferase, units/L | <40 | 46 | 238 | 262 | 209 | 156 |
Alkaline phosphatase, units/L |
30–120 |
69 |
64 |
53 |
67 |
89 |
Cerebrospinal fluid test results | ||||||
Leukocyte count, cells/mm3 | 0–5 | ND | 2 | ND | ND | ND |
Glucose, mg/dL | 40–70 | ND | 80 | ND | ND | ND |
Protein, mg/dL |
12–60 |
ND |
58 |
ND |
ND |
ND |
Cardiac test results | ||||||
Troponin I, ng/mL | <0.04 | ND | ND | ND | 0.21 | 0.38 |
Troponin T, high sensitivity, ng/L | 0–19 | 14 | 22 | 30 | ND | ND |
Pro-BNP, pg/mL |
5–125 |
ND |
ND |
ND |
4,258 |
ND |
Lipid panel test results | ||||||
Cholesterol, total, mg/dL | <200 | ND | ND | ND | 69 | ND |
Triglycerides, mg/dL |
<150 |
ND |
ND |
ND |
147 |
ND |
Other test results | ||||||
D-dimer, mg/L | 0.00–0.49 | ND | ND | 2.72 | 3.71 | ND |
Creatine kinase, U/L | 24–195 | ND | ND | ND | 8,727 | 11,083 |
Lactic acid, mmol/L | 0.5–2.0 | 1.6 | 1.8 | ND | 2.5 | 2.4 |
Lactate dehydrogenase, U/L | 118–273 | ND | ND | 1,412 | 1,709 | ND |
Ferritin, ng/mL | 30–400 | ND | ND | ND | 47,445 | 174,957 |
Fibrinogen, mg/dL | 170–422 | ND | ND | 199 | 224 | 170 |
C-reactive protein, mg/dL | <0.5 | ND | 1.2 | 0.6 | 0.5 | ND |
Interleukin 2 receptor, pg/mL | 532–1,891 | ND | ND | ND | 9,390 | ND |
*BNP, B-type natriuretic peptide; ND, not done.
1These first authors contributed equally to this article.
Page created: February 17, 2023
Page updated: April 19, 2023
Page reviewed: April 19, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.